国家药监局药审中心关于发布《新冠肺炎疫情期间药物临床试验管理指导原则（试行）》的通告
Sorry, this entry is only available in 中文.類型: 連結 作者: 国家药品监督管理局药品审评中心 連結:...
Expert Commentary, Announcement
Convalescent Plasma for COVID-19: More Questions Than Answers
Sorry, this entry is only available in 中文.類型: 連結 作者: Carlos del Rio 出處: NEJM Journal Watch 連結:...
Discharged COVID-19 Patients Without Symptoms Often Have Positive SARS-CoV-2 PCR Tests
Sorry, this entry is only available in 中文.類型: 連結 作者: Thomas L. Schwenk 出處: NEJM Journal Watch 連結:...
10 things doctors should know about COVID-19
Sorry, this entry is only available in 中文.類型: 連結 作者: Stephen Padilla 出處: MIMS 連結:...
NEJM重磅：美国首项瑞德西韦临床试验初步结果正式发表，作者解释备受争议的临床终点修改问题
Sorry, this entry is only available in 中文.類型: 連結 作者: NEJM医学前沿 出處: NEJM医学前沿 連結:...
《柳叶刀》炮轰特朗普！顶尖医学杂志冲天一怒，号召美国人抛弃他
Sorry, this entry is only available in 中文.類型: 連結 作者: 兵器 出處: 今日头条 連結:...
Don’t rely on contact-tracing apps
Sorry, this entry is only available in 中文.類型: 連結 作者: The Economist 出處: The Economist 連結:...
Does Vitamin D Protect Against COVID-19?
Sorry, this entry is only available in 中文.類型: 連結 作者: JoAnn E. Manson 出處: Medscape 連結:...
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
Sorry, this entry is only available in 中文.類型: 連結 作者: The OpenSAFELY Collaborative et al. 出處: Medrxiv 連結:...
Remdesivir: Drug has ‘clear-cut ‘power to fight coronavirus
Remdesivir cut the duration of symptoms from 15 days down to 11 in clinical trial at hospitals around the world.The full details have not been published……